Fresenius Medical Care AG & Co. KGaA (ETR:FME – Get Rating) has been given a €62.00 ($65.26) price objective by stock analysts at Warburg Research in a note issued to investors on Tuesday, Borsen Zeitung reports. Warburg Research’s price target indicates a potential upside of 7.71% from the company’s previous close.
Several other equities research analysts have also recently issued reports on FME. Deutsche Bank Rese… set a €58.00 ($61.05) price target on Fresenius Medical Care AG & Co. KGaA in a research note on Thursday, May 5th. Stifel Nicolaus set a €60.00 ($63.16) price target on Fresenius Medical Care AG & Co. KGaA in a research note on Friday, February 4th. Credit Suisse Group set a €61.00 ($64.21) price target on Fresenius Medical Care AG & Co. KGaA in a research note on Thursday, May 5th. The Goldman Sachs Group set a €71.00 ($74.74) price target on Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday, March 22nd. Finally, Barclays set a €68.00 ($71.58) price target on Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday, April 26th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Fresenius Medical Care AG & Co. KGaA currently has an average rating of “Hold” and a consensus target price of €64.74 ($68.15).
Shares of Fresenius Medical Care AG & Co. KGaA stock traded down €1.02 ($1.07) on Tuesday, hitting €57.56 ($60.59). The stock had a trading volume of 512,462 shares, compared to its average volume of 704,197. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 95.29. The stock has a market cap of $16.87 billion and a price-to-earnings ratio of 17.39. The business’s 50 day moving average is €59.80 and its two-hundred day moving average is €58.52. Fresenius Medical Care AG & Co. KGaA has a twelve month low of €50.98 ($53.66) and a twelve month high of €71.14 ($74.88).
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
- If PetMeds Is A Good Buy There Will Be A Better Signal
- Insiders Buy Occidental Petroleum Ahead Of Q1 Earnings
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
- Shopify (NYSE: SHOP) Approaches Key Support Level
- Follow The Money To Cigna
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.